These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 11464906)

  • 41. Expression and sequence analysis of candidates for the 1p36.31 tumor suppressor gene deleted in neuroblastomas.
    Okawa ER; Gotoh T; Manne J; Igarashi J; Fujita T; Silverman KA; Xhao H; Mosse YP; White PS; Brodeur GM
    Oncogene; 2008 Jan; 27(6):803-10. PubMed ID: 17667943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid and accurate determination of MYCN copy number and 1p deletion in neuroblastoma by quantitative PCR.
    Anderson J; Gibson S; Williamson D; Rampling D; Austin C; Shipley J; Sebire N; Brock P
    Pediatr Blood Cancer; 2006 Jun; 46(7):820-4. PubMed ID: 16220551
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of a region on chromosome 1p in ovarian serous carcinoma that is frequently deleted in uterine papillary serous carcinoma.
    Herzog TJ; Kowalski LD; Liu H; Arlt M; Swisher E
    Gynecol Oncol; 2001 Jul; 82(1):139-42. PubMed ID: 11426975
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deletion mapping on the short arm of chromosome 1 in Merkel cell carcinoma.
    Leonard JH; Cook AL; Nancarrow D; Hayward N; Van Gele M; Van Roy N; Speleman F
    Cancer Detect Prev; 2000; 24(6):620-7. PubMed ID: 11198276
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Identification of the breakpoint-flanking markers on chromosomes 1 and 17 of a constitutional translocation T(1;17)(P36;Q12-21) in a patient with neuroblastoma].
    Laureys GG
    Verh K Acad Geneeskd Belg; 1995; 57(5):389-422. PubMed ID: 8571670
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of the small interstitial deletion at chromosome band 1p34-p35 and its association with poor outcome in oligodendroglial tumors.
    Iuchi T; Namba H; Iwadate Y; Shishikura T; Kageyama H; Nakamura Y; Ohira M; Yamaura A; Osato K; Sakiyama S; Nakagawara A
    Genes Chromosomes Cancer; 2002 Oct; 35(2):170-5. PubMed ID: 12203781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma.
    Lázcoz P; Muñoz J; Nistal M; Pestaña A; Encío I; Castresana JS
    BMC Cancer; 2006 Oct; 6():254. PubMed ID: 17064406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative genomic hybridization (CGH) analysis of neuroblastomas--an important methodological approach in paediatric tumour pathology.
    Brinkschmidt C; Christiansen H; Terpe HJ; Simon R; Boecker W; Lampert F; Stoerkel S
    J Pathol; 1997 Apr; 181(4):394-400. PubMed ID: 9196436
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rapid detection of MYCN gene amplification in neuroblastomas using the polymerase chain reaction.
    Crabbe DC; Peters J; Seeger RC
    Diagn Mol Pathol; 1992 Dec; 1(4):229-34. PubMed ID: 1342970
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene expression profiling of 1p35-36 genes in neuroblastoma.
    Janoueix-Lerosey I; Novikov E; Monteiro M; Gruel N; Schleiermacher G; Loriod B; Nguyen C; Delattre O
    Oncogene; 2004 Aug; 23(35):5912-22. PubMed ID: 15195138
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fluorescence in situ hybridization analysis of chromosome 1p36 deletions in human MYCN amplified neuroblastoma.
    Komuro H; Valentine MB; Rowe ST; Kidd VJ; Makino S; Brodeur GM; Cohn SL; Look AT
    J Pediatr Surg; 1998 Nov; 33(11):1695-8. PubMed ID: 9856898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Translocation junctions cluster at the distal short arm of chromosome 1 (1p36.1-2) in human neuroblastoma cells.
    Barker PE; Savelyeva L; Schwab M
    Oncogene; 1993 Dec; 8(12):3353-8. PubMed ID: 8247537
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interstitial and large chromosome 1p deletion occurs in localized and disseminated neuroblastomas and predicts an unfavourable outcome.
    Iolascon A; Lo Cunsolo C; Giordani L; Cusano R; Mazzocco K; Boumgartner M; Ghisellini P; Faienza MF; Boni L; De Bernardi B; Conte M; Romeo G; Tonini GP
    Cancer Lett; 1998 Aug; 130(1-2):83-92. PubMed ID: 9751260
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients.
    Henrich KO; Fischer M; Mertens D; Benner A; Wiedemeyer R; Brors B; Oberthuer A; Berthold F; Wei JS; Khan J; Schwab M; Westermann F
    Clin Cancer Res; 2006 Jan; 12(1):131-8. PubMed ID: 16397034
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death.
    Ejeskär K; Krona C; Carén H; Zaibak F; Li L; Martinsson T; Ioannou PA
    BMC Cancer; 2005 Dec; 5():161. PubMed ID: 16359544
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of heterozygosity for chromosome 1p in familial neuroblastoma.
    Tonini GP; Lo Cunsolo C; Cusano R; Iolascon A; Dagnino M; Conte M; Milanaccio C; De Bernardi B; Mazzocco K; Scaruffi P
    Eur J Cancer; 1997 Oct; 33(12):1953-6. PubMed ID: 9516831
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distinct target regions for chromosome 1p deletions in parathyroid adenomas and carcinomas.
    Välimäki S; Forsberg L; Farnebo LO; Larsson C
    Int J Oncol; 2002 Oct; 21(4):727-35. PubMed ID: 12239610
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deletion of 1p36 in childhood endodermal sinus tumors by two-color fluorescence in situ hybridization: a pediatric oncology group study.
    Perlman EJ; Valentine MB; Griffin CA; Look AT
    Genes Chromosomes Cancer; 1996 May; 16(1):15-20. PubMed ID: 9162192
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preferential loss of paternal 19q, but not 1p, alleles in oligodendrogliomas.
    Sanson M; Leuraud P; Marie Y; Delattre JY; Hoang-Xuan K
    Ann Neurol; 2002 Jul; 52(1):105-7. PubMed ID: 12112056
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastoma.
    Spitz R; Hero B; Ernestus K; Berthold F
    Med Pediatr Oncol; 2003 Jul; 41(1):30-5. PubMed ID: 12764740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.